Botulinum toxin was found to be relatively safe and effective for treating excessive drooling in people with Parkinson’s disease,…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Damage to the genetic material in mitochondria, cells’ energy production centers, may trigger the spread of nerve cell death in…
A year of treatment with levodopa plus benserazide led to greater clinical improvements among Parkinson’s disease patients who…
Cognition tests given virtually showed results similar to in-person evaluations for Parkinson’s disease patients with no or mild cognitive…
Scientists have discovered that long-term changes in a biomarker of nerve damage, called neurofilament light chain (NfL), could be used…
Motor abilities assessed via multiple sensors on a smartwatch correlated well with motor function as rated by clinicians, and could…
Michael J. Fox has received the 2023 Elevate Prize Catalyst Award in recognition of his work with the Michael…
Note: This story was updated Sept. 20, 2023, to reflect that Acadia is working on Nuplazid’s development as a…
The Parkinson’s Foundation has launched a day of giving in an effort to encourage Parkinson’s disease awareness and…
The 2024 Breakthrough Prize in Life Sciences has been awarded to three researchers who made groundbreaking discoveries related to the…